THE CHALLENGE
Elderly head and neck cancer patients were facing a devastating reality: they were too frail for aggressive chemotherapy but needed more than standard radiation therapy could deliver. These vulnerable patients – many dealing with advanced disease while managing other health conditions – were running out of effective treatment options. Meanwhile, Nanobiotix had developed revolutionary nanomedicine technology that could potentially supercharge radiation therapy, but they faced the challenge of reaching elderly patients who were often overwhelmed by complex medical decisions and skeptical of experimental treatments.
THE SOLUTION
e transformed Nanobiotix’s complex nanomedicine science into a message of hope and possibility for elderly cancer patients and their families. Rather than focusing on nanotechnology details that could overwhelm patients, we positioned their radioenhancer as the breakthrough that could help radiation therapy work better – giving patients a fighting chance when other options weren’t available. Our comprehensive study brand spanned their entire clinical trial portfolio, creating educational materials that helped patients understand how nanoscale physics could enhance their treatment while building trust in Nanobiotix’s 17-year track record of innovation. The result: a patient recruitment strategy that not only filled their head and neck cancer studies but also established Nanobiotix as the nanomedicine company that puts patient hope at the center of cutting-edge cancer research.
